“High-dose” UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides-Reference-Cited by-同舟云学术

“High-dose” UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides

Published:2001-04 Issue:4 Volume:44 Page:629-633
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Zane Cristina,Leali Carla,Airò Paolo,De Panfilis Giuseppe,Pinton Piergiacomo Calzavara

Publisher

Elsevier BV

Subject

Dermatology

Reference12 articles.

1. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer;Willemze;Blood,1997

2. Cutaneous T cell lymphoma: update of treatment;Zackheim;Dermatology,1999

3. Ultraviolet B phototherapy for early stage cutaneous T cell lymphoma;Ramsay;Arch Dermatol,1992

4. Ultraviolet A1 (340 to 400 nm) phototherapy for cutaneous T-cell lymphoma;Plettemberg;J Am Acad Dermatol,1999

5. The optics of human skin;Anderson;J Invest Dermatol,1981

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical, histopathological and immunohistochemical evaluation of ultraviolet A1 treatment in early‐stage mycosis fungoides;Photodermatology, Photoimmunology & Photomedicine;2024-01

2. The realistic positioning of UVA1 phototherapy after 25 years of clinical experience and the availability of new biologics and small molecules: a retrospective clinical study;Frontiers in Medicine;2023-11-21

3. Phototherapy and mycosis fungoides: what’s new?;Dermatology Reports;2023-10-17

4. Ultraviolet A Combined with Narrow-Band Ultraviolet B is an Effective Treatment Modality for Early Folliculotropic Mycosis Fungoides and Early Mycosis Fungoides Refractory to Narrow-Band Ultraviolet B: A Retrospective Cohort Study;Dermatologic Therapy;2023-09-01

5. Efficacy of ultraviolet A 1 phototherapy for inflammatory, sclerotic and neoplastic dermatological diseases: A 10‐year tertiary referral center experience;Photodermatology, Photoimmunology & Photomedicine;2022-09-13